Drug FDA Class III Ongoing Mislabeling
Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02
Eugia US LLC Published Jun 10, 2026
Risk level
Class IIIUnlikely to cause harm, but violates labeling or manufacturing rules.
Severity score 40/100
What should you do?
- Check whether you have this product, using the lot codes, UPCs, and dates listed below.
- Do not eat, serve, or sell the affected product.
- Return it to the place of purchase for a refund, or throw it away in a sealed bag so people and animals can’t get to it.
- Contact Eugia US LLC or your place of purchase with questions, and see the source record below for full details.
Reason for recall
Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
Affected products (1)
Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02
LIDOLOG KIT · 168,300 vials
NDC: 76420-760, 76420-760-01, 55150-164-02, 70121-1049-5, 67777-419-02
Lot codes: 3LC26029A, 3LC26031A
Code info: Lot, expiry: Lot 3LC26029A, exp Feb-2029; Lot 3LC26031A, exp Mar-2029
Affected areas
Nationwide
Timeline
- InitiatedMay 18, 2026
- PublishedJun 10, 2026
- Recall number
- D-0552-2026
- Agency
- U.S. Food and Drug Administration
- Country
- US
FDA records come from the openFDA drug enforcement-report dataset — the agency's full weekly enforcement list. Most entries are not issued as consumer press releases, so they won't appear on fda.gov/recalls or in a web search. The source record link above resolves this exact recall by its number.